Larvol Delta - Ficerafusp-Alfa-Plus-Pembrolizumab-Demonstrated-Differentiated-ThreeYear-Overall-Survival-and-Deep-Responses-Driven-by-TGF-Inhibition-in-1L-RM-HPVNegative-HNSCC

ficerafusp alfa (BCA101) - Bicara Therapeutics

https://www.globenewswire.com/news-release/2026/05/21/3299780/0/en/Ficerafusp-Alfa-Plus-Pembrolizumab-Demonstrated-Differentiated-Three-Year-Overall-Survival-and-Deep-Responses-Driven-by-TGF-%CE%B2-Inhibition-in-1L-R-M-HPV-Negative-HNSCC.html

May 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next